## Peritonsillar Abscess: Antibiotic Management **Key Point:** Peritonsillar abscess is a polymicrobial infection involving both aerobic (Streptococcus pyogenes, S. pneumoniae) and anaerobic organisms (Peptostreptococcus, Prevotella, Fusobacterium). Empirical therapy must cover both groups. ### Why Amoxicillin-Clavulanate? **High-Yield:** Amoxicillin-clavulanate is the first-line antibiotic for peritonsillar abscess because: - **Broad spectrum:** covers Group A Streptococcus (most common aerobe) and anaerobes - **β-lactamase inhibitor:** clavulanate protects amoxicillin from anaerobic β-lactamase production - **Excellent tissue penetration:** reaches therapeutic levels in pharyngeal tissues and pus - **Oral bioavailability:** suitable for outpatient management post-drainage **Clinical Pearl:** The standard regimen is amoxicillin-clavulanate 625 mg (500 mg amoxicillin + 125 mg clavulanate) three times daily for 7–10 days, or 875/125 mg twice daily. ### Comparative Antibiotic Spectrum | Antibiotic | Aerobic Coverage | Anaerobic Coverage | β-lactamase Resistant | First-Line? | |---|---|---|---|---| | **Amoxicillin-clavulanate** | ✓ (Strep, Pneumo) | ✓ (Peptostreptococcus, Prevotella) | ✓ | **YES** | | Cephalexin (1st gen) | ✓ (Strep, Pneumo) | ✗ (poor) | Partial | No | | Clindamycin | ✓ (Strep) | ✓ (anaerobes) | ✓ | Alternative only | | Azithromycin | ✓ (Strep) | ✗ (poor) | ✗ | No | **Mnemonic:** **PABA** = **P**enicillin + **A**naerobes = **B**est **A**ntibiotic → Amoxicillin-clavulanate (penicillin + β-lactamase inhibitor). ### Management Algorithm ```mermaid flowchart TD A[Peritonsillar Abscess Suspected]:::outcome --> B{Diagnosis Confirmed?}:::decision B -->|Yes| C[Drainage + Antibiotics]:::action C --> D[Amoxicillin-clavulanate 625 mg TDS]:::action D --> E[7-10 days oral therapy]:::action E --> F[Clinical resolution]:::outcome B -->|No| G[Supportive care + NSAIDs]:::action ``` **Warning:** Do NOT use cephalexin alone — it has poor anaerobic coverage and high failure rates. Clindamycin is reserved for penicillin-allergic patients.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.